326 related articles for article (PubMed ID: 25913181)
1. A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
Ridolo E; Montagni M; Melli V; Bonzano L; Incorvaia C; Canonica GW
Ther Deliv; 2015; 6(6):653-9. PubMed ID: 25913181
[TBL] [Abstract][Full Text] [Related]
2. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
3. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
[TBL] [Abstract][Full Text] [Related]
4. Azelastine and fluticasone nasal spray: any advantage?
Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
6. MP29-02: a breakthrough for the treatment of allergic rhinitis.
Bernstein JA
Expert Opin Pharmacother; 2013 Oct; 14(15):2101-13. PubMed ID: 23977840
[TBL] [Abstract][Full Text] [Related]
7. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
Klimek L; Bousquet J; Price D
Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
[TBL] [Abstract][Full Text] [Related]
8. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
[TBL] [Abstract][Full Text] [Related]
9. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
Carr W; Bernstein J; Lieberman P; Meltzer E; Bachert C; Price D; Munzel U; Bousquet J
J Allergy Clin Immunol; 2012 May; 129(5):1282-1289.e10. PubMed ID: 22418065
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
[TBL] [Abstract][Full Text] [Related]
12. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
13. A novel and effective approach to treating rhinitis with nasal antihistamines.
Kaliner MA
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):383-90; quiz 391-2, 418. PubMed ID: 18051206
[TBL] [Abstract][Full Text] [Related]
14. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
Berger WE; Shah S; Lieberman P; Hadley J; Price D; Munzel U; Bhatia S
J Allergy Clin Immunol Pract; 2014; 2(2):179-85. PubMed ID: 24607046
[TBL] [Abstract][Full Text] [Related]
15. Azelastine/fluticasone propionate(Dymista) for seasonal allergic rhinitis.
Med Lett Drugs Ther; 2012 Oct; 54(1402):85-7. PubMed ID: 23114738
[No Abstract] [Full Text] [Related]
16. MP29-02 for the treatment of seasonal allergic rhinitis: a review of clinical pharmacology, efficacy and safety.
Berger WE
Expert Rev Clin Immunol; 2013 Sep; 9(9):803-11. PubMed ID: 24070043
[TBL] [Abstract][Full Text] [Related]
17. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
19. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
Kalpaklioglu AF; Kavut AB
Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]